<?xml version="1.0" encoding="utf-8"?>
<rss 
  version="2.0">
  <channel xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/">
    <title>Cognoa</title>
    <link>https://www.globenewswire.com/rssfeed/organization/GqdnSmUgd99OMzaWryaL8w==</link>
    <description>Contains the last 20 releases</description>
    <copyright>Copyright 2020, Cognoa</copyright>
    <managingEditor>newsdesk@globenewswire.com (NewsDesk)</managingEditor>
    <lastBuildDate>Wed, 23 Sep 2020 13:03:00 GMT</lastBuildDate>
    <webMaster>webmaster@globenewswire.com (Webmaster)</webMaster>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/09/23/2098045/0/en/Cognoa-Seeks-FDA-Clearance-for-Breakthrough-Digital-Autism-Diagnostic-Device-After-Successful-Pivotal-Study.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/09/23/2098045/0/en/Cognoa-Seeks-FDA-Clearance-for-Breakthrough-Digital-Autism-Diagnostic-Device-After-Successful-Pivotal-Study.html</link>
      <title>Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study</title>
      <description><![CDATA[Cognoa’s autism diagnostic device is positioned to be the first FDA-cleared digital solution enabling pediatricians to diagnose autism - a paradigm shift in the standard of care <pre>Cognoa’s autism diagnostic device is positioned to be the first FDA-cleared digital solution enabling pediatricians to diagnose autism - a paradigm shift in the standard of care</pre>]]></description>
      <pubDate>Wed, 23 Sep 2020 13:03 GMT</pubDate>
      <dc:identifier>2098045</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Wed, 23 Sep 2020 13:03 GMT</dc:modified>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Health</dc:subject>
      <dc:subject>Press releases</dc:subject>
      <dc:subject>Regulatory information</dc:subject>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.html</link>
      <title>Cognoa Appoints Industry Leader David Happel as New Chief Executive Officer</title>
      <description><![CDATA[Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries <pre>Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries</pre>]]></description>
      <pubDate>Tue, 24 Mar 2020 10:05 GMT</pubDate>
      <dc:identifier>2005312</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Tue, 24 Mar 2020 10:05 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/png"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/90ffce06-565f-4cf1-900c-701984419653">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.html">
    <img src="https://ml.globenewswire.com/Resource/Download/90ffce06-565f-4cf1-900c-701984419653" width="600" align="left" border="0" alt="Photo" title="Cognoa appoints industry leader David Happel as new Chief Executive Officer. Happel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries. " />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Press releases</dc:subject>
      <dc:keyword>pediatric behavioral health</dc:keyword>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>digital diagnostics</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>early intervention</dc:keyword>
      <dc:keyword>behavioral health</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.html</link>
      <title>Cognoa Appoints Dr. Colleen Kraft Senior Medical Director of Clinical Adoption</title>
      <description><![CDATA[AAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps <pre>AAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps</pre>]]></description>
      <pubDate>Thu, 05 Mar 2020 14:03 GMT</pubDate>
      <dc:identifier>1995917</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Thu, 05 Mar 2020 14:03 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/378fb37b-8242-4013-a4b1-4292e2690389">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.html">
    <img src="https://ml.globenewswire.com/Resource/Download/378fb37b-8242-4013-a4b1-4292e2690389" width="600" align="left" border="0" alt="Photo" title="AAP 2018 Past President, Dr. Colleen Kraft, Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Press releases</dc:subject>
      <dc:keyword>Digital Therapeutics</dc:keyword>
      <dc:keyword>Pediatric Behavioral Health</dc:keyword>
      <dc:keyword>Autism</dc:keyword>
      <dc:keyword>#putkids1st</dc:keyword>
      <dc:keyword>#earlyintervention</dc:keyword>
      <dc:keyword>@AmerAcadPeds</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.html</link>
      <title>Cognoa CEO to Participate in the Cowen and Company 40th Annual Healthcare Conference</title>
      <description><![CDATA[<p>Palo Alto, Calif., Feb.  26, 2020  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=kQXDuoYmL8Z_hX4RSt-z534agalkLWo8SYu0habUURUgUxMIbwabOqb0GXvibgFiMLqQay41O_BVH7dUfQvEjQ==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, the leading digital therapeutics company focused on pediatric behavioral health, announced today that CEO, Brent Vaughan, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference with executives from Akili Interactive Labs, Click Therapeutics and Pear Therapeutics. The panel will take place at 1:30 p.m. EST on Tuesday, March 3, at the Boston Marriott Copley Place.</p>]]></description>
      <pubDate>Wed, 26 Feb 2020 14:05 GMT</pubDate>
      <dc:identifier>1991052</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Wed, 26 Feb 2020 14:05 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/4257e6ec-eb36-4457-afd4-031d37455daa">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.html">
    <img src="https://ml.globenewswire.com/Resource/Download/4257e6ec-eb36-4457-afd4-031d37455daa" width="600" align="left" border="0" alt="Photo" title="Brent Vaughan, CEO and Co-Founder of Cognoa, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference at 1:30 p.m. EST on Tuesday, March 3, at the Boston Marriott Copley Place." />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Calendar of Events</dc:subject>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Press releases</dc:subject>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>digital health</dc:keyword>
      <dc:keyword>healthcare</dc:keyword>
      <dc:keyword>#cowenhealthcare</dc:keyword>
      <dc:keyword>pediatrics</dc:keyword>
      <dc:keyword>behavioral health</dc:keyword>
      <dc:keyword>healthtech</dc:keyword>
      <dc:keyword>AI</dc:keyword>
      <dc:keyword>mhealth</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.html</link>
      <title>Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care</title>
      <description><![CDATA[<p>PASADENA and PALO ALTO, Calif., Feb.  11, 2020  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6r5wWKRNy0avSliXy_FpUTs7D2vqgxkKA2OBqIlt-9TvlNHjevhh-Owq-8EPx8jlxhbJN8BzMHPg2UMGS_WlalMWvHlqigwJb7jNMhMJ1Xy_YOUyMBbbP2U7FKDi_M0K" rel="nofollow" target="_blank" title="Autism Learning Partners">Autism Learning Partners</a> ("ALP"), a national leader in the treatment of autism and other developmental disabilities, and <a href="https://www.globenewswire.com/Tracker?data=2awkfYuFaVIeTLbvtLKUdyRX2cKwjECsppjiKxn7Pp-mhz4Xn_37CTnUXEuggQ76EiZ69RKeErDhQ0JYkQbvPg==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, the leading digital therapeutics company focused on pediatric behavioral health, announced today a partnership designed to accelerate the diagnosis of autism to enable interventions earlier, when there is the greatest potential to improve lifelong outcomes.</p>]]></description>
      <pubDate>Tue, 11 Feb 2020 14:00 GMT</pubDate>
      <dc:identifier>1983107</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Tue, 11 Feb 2020 14:01 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/png"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/1cc2a29e-0ea5-4e65-9e0a-fefc8cf9101a">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.html">
    <img src="https://ml.globenewswire.com/Resource/Download/1cc2a29e-0ea5-4e65-9e0a-fefc8cf9101a" width="600" align="left" border="0" alt="Photo" title="Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care 
" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Company Announcement</dc:subject>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>digital medicines</dc:keyword>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>ABA Therapy</dc:keyword>
      <dc:keyword>early diagnosis</dc:keyword>
      <dc:keyword>pediatrics</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.html</link>
      <title>Cognoa Executives to Speak at DTx West 2020</title>
      <description><![CDATA[<p>Palo Alto, Calif., Feb.  10, 2020  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=KxTGhUjezY6jtz-lea4LzYrP33PRF1riBrHtXAbGncYPZ_2960Kdr3Cn0MXazMEwsJlvRcsPYDNEBUdl2mM3NQ==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, the leading digital therapeutics company focused on pediatric behavioral health, announced today that three company executives will be on stage at the third annual<a href="https://www.globenewswire.com/Tracker?data=ZfGkmVbItZ9vDNYiuYDcIIvozMIGSRZCi_RPDDkUy70DmNgbLq2wC6Cn03EQYkQa-ST0ZdLhEpWsjPSdB3UMHQ==" rel="nofollow" target="_blank" title="DTx West 2020"> DTx West 2020</a>, taking place in San Mateo, California, February 18 to 20.  </p>]]></description>
      <pubDate>Mon, 10 Feb 2020 14:00 GMT</pubDate>
      <dc:identifier>1982378</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Mon, 10 Feb 2020 15:49 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/ffd82331-2af5-4ebc-b30d-90e05a7e0ccb">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.html">
    <img src="https://ml.globenewswire.com/Resource/Download/ffd82331-2af5-4ebc-b30d-90e05a7e0ccb" width="600" align="left" border="0" alt="Photo" title="Brent Vaughan, CEO and co-founder, Cognoa" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Company Announcement</dc:subject>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>#DTxWest</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
      <dc:keyword>digital health</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.html</link>
      <title>Cognoa Named to the 2020 Global Digital Health 100 By The Journal of mHealth</title>
      <description><![CDATA[International Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology <pre>International Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology</pre>]]></description>
      <pubDate>Wed, 29 Jan 2020 14:00 GMT</pubDate>
      <dc:identifier>1976820</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Wed, 29 Jan 2020 14:00 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/jpeg"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/0622a232-ffac-4fe6-9b17-957aa3031871">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.html">
    <img src="https://ml.globenewswire.com/Resource/Download/0622a232-ffac-4fe6-9b17-957aa3031871" width="600" align="left" border="0" alt="Photo" title="Cognoa is named a 2020 Global Digital Health 100 Company by The Journal of mHealth" />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Health</dc:subject>
      <dc:keyword>Digital health</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
      <dc:keyword>Global Digital Health 100</dc:keyword>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>Digital therapeutics</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>pediatricians</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/01/24/1974688/0/en/UPDATED-Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/01/24/1974688/0/en/UPDATED-Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html</link>
      <title>UPDATED:  Austin Regional Clinic Recruiting Families for Clinical Trial Testing Mobile Device to Aid Autism Diagnosis in Young Children</title>
      <description><![CDATA[Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months <pre>Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months</pre>]]></description>
      <pubDate>Fri, 24 Jan 2020 01:38 GMT</pubDate>
      <dc:identifier>1974688</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Fri, 24 Jan 2020 01:37 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/png"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/e2d09d83-1e8e-45e2-8606-4cba18ed95c4">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/01/24/1974688/0/en/UPDATED-Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html">
    <img src="https://ml.globenewswire.com/Resource/Download/e2d09d83-1e8e-45e2-8606-4cba18ed95c4" width="600" align="left" border="0" alt="Photo" title="Austin Regional Clinic (ARC) is a multispecialty medical group committed to providing comprehensive healthcare services throughout the greater Austin area. Founded by three physicians in 1980, ARC now provides health care to over 500,000 area residents in 27 locations in 11 cities, including both primary and specialty care. ARC is unique to the Central Texas area because of the widespread locations, convenient services, and quality assurance programs. ARC patients enjoy access to such conveniences as same-day appointments, 24/7 online and phone appointment scheduling, ARC MyChart patient portal, After Hours Clinics, and nursing services through the night. Most ARC clinics also offer on-site radiology and lab services and some clinics offer specialty programs such as a travel clinic and Healthiness program. For more information, visit www.austinregionalclinic.com." />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Health</dc:subject>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>digital medicines</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
      <dc:keyword>DTX</dc:keyword>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>Austin Regional Clinic</dc:keyword>
      <dc:keyword>clinical trial</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/01/23/1974508/0/en/Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/01/23/1974508/0/en/Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html</link>
      <title>Austin Regional Clinic Recruiting Families for Clinical Trial Testing Mobile Device to Aid Autism Diagnosis in Young Children</title>
      <description><![CDATA[Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months <pre>Cognoa’s Autism Diagnostic is Designed for Pediatricians to Use with Children as Young as 18 Months</pre>]]></description>
      <pubDate>Thu, 23 Jan 2020 17:54 GMT</pubDate>
      <dc:identifier>1974508</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Thu, 23 Jan 2020 17:54 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/png"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/c094a5c8-fd10-452c-bd58-10d3ef687eea">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2020/01/23/1974508/0/en/Austin-Regional-Clinic-Recruiting-Families-for-Clinical-Trial-Testing-Mobile-Device-to-Aid-Autism-Diagnosis-in-Young-Children.html">
    <img src="https://ml.globenewswire.com/Resource/Download/c094a5c8-fd10-452c-bd58-10d3ef687eea" width="600" align="left" border="0" alt="Photo" title="Austin Regional Clinic (ARC) is a multispecialty medical group committed to providing comprehensive healthcare services throughout the greater Austin area. Founded by three physicians in 1980, ARC now provides health care to over 500,000 area residents in 27 locations in 11 cities, including both primary and specialty care. ARC is unique to the Central Texas area because of the widespread locations, convenient services, and quality assurance programs. ARC patients enjoy access to such conveniences as same-day appointments, 24/7 online and phone appointment scheduling, ARC MyChart patient portal, After Hours Clinics, and nursing services through the night. Most ARC clinics also offer on-site radiology and lab services and some clinics offer specialty programs such as a travel clinic and Healthiness program. For more information, visit www.austinregionalclinic.com." />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Health</dc:subject>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>digital medicines</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
      <dc:keyword>DTX</dc:keyword>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>Austin Regional Clinic</dc:keyword>
      <dc:keyword>clinical trial</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2020/01/06/1966474/0/en/Cognoa-CEO-and-CMO-Presenting-at-Digital-Medicine-Medtech-Showcase-2020-and-InnovatorMD-Global-Summit-in-San-Francisco.html</guid>
      <link>https://www.globenewswire.com/news-release/2020/01/06/1966474/0/en/Cognoa-CEO-and-CMO-Presenting-at-Digital-Medicine-Medtech-Showcase-2020-and-InnovatorMD-Global-Summit-in-San-Francisco.html</link>
      <title>Cognoa CEO and CMO Presenting at Digital Medicine &amp; Medtech Showcase 2020 and InnovatorMD Global Summit in San Francisco</title>
      <description><![CDATA[<p>PALO ALTO, Calif., Jan.  06, 2020  (GLOBE NEWSWIRE) -- <u><a href="https://www.globenewswire.com/Tracker?data=WPc1wa6mtstRu27TdU1bPQ13HFeqI8tsAchlDeK8uRhrQ4OMQfmdwvQOKfw_SS1rS2scUkygZUSUZ39MscLdBg==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a></u>, the leading digital therapeutics company focused on pediatric behavioral health, announced today that senior executives will be speaking at two healthcare innovation and investor conferences in San Francisco.<br></p>]]></description>
      <pubDate>Mon, 06 Jan 2020 13:30 GMT</pubDate>
      <dc:identifier>1966474</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Mon, 06 Jan 2020 13:30 GMT</dc:modified>
      <dc:subject>Calendar of Events</dc:subject>
      <dc:subject>Company Announcement</dc:subject>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>digital medicines</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
      <dc:keyword>#DigiMedShow</dc:keyword>
      <dc:keyword>#JPM20</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html</link>
      <title>Cognoa Wins 2019 Fierce Innovation Life Science Award</title>
      <description><![CDATA[<p>Palo Alto, Calif., Dec.  18, 2019  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ShJfftAooqnPBjwOpE1cOmzjOlGhYDwrndVtuj0FHaWcRxM-MAuI6AbiihlOYsQEQ91y8HKQ9e1PBvK9hVplTA==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, a company at the forefront of pediatric behavioral health, has won the <a href="https://www.globenewswire.com/Tracker?data=lmv8yfKVAPY47H41-1NbAVb9OGCmd6_OQcjZSENFXnGzUiRDoi44wRKS_d7TkO9J9LO2zA07Xt8553r_RSBQb6cM90SWXk4A9_fT5YpMf6W0Lyh4pvDvQYB-wrj16fJBGh6yK5n1XEBSPS4xQkbFlscrUYRFdvyLn3ggC4GM_C5mOqZYDFYPwnnO1Eb5_y4x" rel="nofollow" target="_blank" title="Fierce Innovation Life Science Award">Fierce Innovation Life Science Award</a> for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity to receive treatments earlier when they can have the greatest impact.</p>]]></description>
      <pubDate>Wed, 18 Dec 2019 20:05 GMT</pubDate>
      <dc:identifier>1962445</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Wed, 18 Dec 2019 22:10 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/png"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/e84a7072-6373-49f7-ac80-0c6cb665e8f2">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html">
    <img src="https://ml.globenewswire.com/Resource/Download/e84a7072-6373-49f7-ac80-0c6cb665e8f2" width="600" align="left" border="0" alt="Photo" title="Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Sciences Award for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity to receive treatments earlier when they can have the greatest impact. Cognoa’s digital therapeutics and medicines will provide a continuum of care from identifying at-risk children to empowering early diagnosis and treatment of behavioral health conditions. By targeting the critical, early neurodevelopmental windows, Cognoa’s digital therapeutics promote neuromodulation of specific brain networks, improving functional connectivity to create lifelong gains. More information is available at: https://www.cognoa.com/ " />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Health</dc:subject>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>digital medicine</dc:keyword>
      <dc:keyword>Fierce Innovation Awards</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>digital diagnostic</dc:keyword>
      <dc:keyword>AI</dc:keyword>
      <dc:keyword>pediatricians</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/12/05/1956854/0/en/COGNOA-SELECTED-AS-FINALIST-IN-FIERCE-INNOVATION-AWARDS-LIFE-SCIENCES-EDITION-2019.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/12/05/1956854/0/en/COGNOA-SELECTED-AS-FINALIST-IN-FIERCE-INNOVATION-AWARDS-LIFE-SCIENCES-EDITION-2019.html</link>
      <title>COGNOA SELECTED AS FINALIST IN FIERCE INNOVATION AWARDS – LIFE SCIENCES EDITION 2019</title>
      <description><![CDATA[Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children <pre>Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children</pre>]]></description>
      <pubDate>Thu, 05 Dec 2019 14:15 GMT</pubDate>
      <dc:identifier>1956854</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Thu, 05 Dec 2019 14:15 GMT</dc:modified>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Health</dc:subject>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>Fierce Innovation Awards</dc:keyword>
      <dc:keyword>Digital Therapeutics</dc:keyword>
      <dc:keyword>AI in medicine</dc:keyword>
      <dc:keyword>digital medicines</dc:keyword>
      <dc:keyword>autism</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/12/02/1954805/0/en/COGNOA-APPOINTS-SEASONED-BIOTECH-EXECUTIVE-AS-CFO.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/12/02/1954805/0/en/COGNOA-APPOINTS-SEASONED-BIOTECH-EXECUTIVE-AS-CFO.html</link>
      <title>COGNOA APPOINTS SEASONED BIOTECH EXECUTIVE AS CFO</title>
      <description><![CDATA[James Welch brings two decades experience scaling high-growth companies to Cognoa as company prepares for commercialization <pre>James Welch brings two decades experience scaling high-growth companies to Cognoa as company prepares for commercialization</pre>]]></description>
      <pubDate>Mon, 02 Dec 2019 13:55 GMT</pubDate>
      <dc:identifier>1954805</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Mon, 02 Dec 2019 13:55 GMT</dc:modified>
      <media:content
        medium="image"
        type="image/png"
        width="600"
        url="https://ml.globenewswire.com/Resource/Download/ccce2377-7be8-4deb-a2b6-13d6c886cb3f">
        <media:text
          type="html"><![CDATA[<p>
  <a href="https://www.globenewswire.com/news-release/2019/12/02/1954805/0/en/COGNOA-APPOINTS-SEASONED-BIOTECH-EXECUTIVE-AS-CFO.html">
    <img src="https://ml.globenewswire.com/Resource/Download/ccce2377-7be8-4deb-a2b6-13d6c886cb3f" width="600" align="left" border="0" alt="Photo" title="James (Jim) H. Welch has been appointed CFO of Cognoa. Welch will oversee financial planning, operations and investor relations as the company advances its digital therapeutics and digital medicines towards commercialization in 2020. Welch has an impressive 20-year track record of success guiding emerging biotech companies—managing two IPOs, as well as raising a combined total of $800M in support of research, development, and preparation for commercialization. “We are delighted to have Jim join the Cognoa leadership team. Jim’s experience and expertise scaling high-growth biotech companies make him the ideal CFO for Cognoa as we look to gain FDA clearance and commercialize our pipeline of prescription digital therapeutics,” said Brent Vaughan, co-founder, and CEO of Cognoa. " />
  </a>
</p><br clear="all" />]]></media:text>
        <media:credit
          role="publishing company">GlobeNewswire Inc.</media:credit>
      </media:content>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Health</dc:subject>
      <dc:keyword>Digital Therapeutics</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>pediatric Behavioral Health</dc:keyword>
      <dc:keyword>CFO</dc:keyword>
      <dc:keyword>Commercialization</dc:keyword>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>digital medicines</dc:keyword>
      <dc:keyword>biotech</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/11/14/1947500/0/en/COGNOA-TO-PARTICIPATE-IN-BTIG-DIGITAL-HEALTH-AND-EVERCORE-ISI-HealthCONx-CONFERENCES.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/11/14/1947500/0/en/COGNOA-TO-PARTICIPATE-IN-BTIG-DIGITAL-HEALTH-AND-EVERCORE-ISI-HealthCONx-CONFERENCES.html</link>
      <title>COGNOA TO PARTICIPATE IN BTIG DIGITAL HEALTH AND EVERCORE ISI HealthCONx CONFERENCES</title>
      <description><![CDATA[<p>Palo Alto, Calif., Nov.  14, 2019  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=VdQhgbUk-ibvYWY9NjN4ZsGptDzyjYzNT3pilLSOZaKLIuDmCmH8m_FTLAvgSZT3qO07mXbhvv2jDfGGOaVibw==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking at two upcoming investor conferences:</p>]]></description>
      <pubDate>Thu, 14 Nov 2019 18:07 GMT</pubDate>
      <dc:identifier>1947500</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Thu, 14 Nov 2019 19:21 GMT</dc:modified>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Health</dc:subject>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>digital medicines</dc:keyword>
      <dc:keyword>Investor conference</dc:keyword>
      <dc:keyword>healthtech</dc:keyword>
      <dc:keyword>behavioral health</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/10/28/1936418/0/en/Cognoa-CEO-Brent-Vaughan-to-Speak-at-HLTH-and-CNS-Summit.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/10/28/1936418/0/en/Cognoa-CEO-Brent-Vaughan-to-Speak-at-HLTH-and-CNS-Summit.html</link>
      <title>Cognoa CEO Brent Vaughan to Speak at HLTH and CNS Summit</title>
      <description><![CDATA[<p>Palo Alto, Calif. and Orlando, Oct.  28, 2019  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=427ypsHCdtRyPPWHN0arqZ237vmR4Dd604JMw0c0CyMDGytamJubovBx39zhCcX_OB1wr8N9fAusdOO00HaElg==" rel="nofollow" target="_blank" title="Cognoa">Cognoa</a>, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking about the future of digital therapeutics at two conferences this week, HLTH and CNS Summit. Andy Molnar, Vice President of Commercialization at Cognoa will also speak at HLTH about reimbursement strategies for digital therapeutics.</p>]]></description>
      <pubDate>Mon, 28 Oct 2019 14:00 GMT</pubDate>
      <dc:identifier>1936418</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Mon, 28 Oct 2019 15:02 GMT</dc:modified>
      <dc:subject>Company Announcement</dc:subject>
      <dc:subject>Health</dc:subject>
      <dc:subject>Trade Show</dc:subject>
      <dc:keyword>#HLTH2019</dc:keyword>
      <dc:keyword>CNS Summit</dc:keyword>
      <dc:keyword>digital therapeutics</dc:keyword>
      <dc:keyword>autism</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/10/24/1935017/0/en/Cognoa-Launches-Pivotal-Study-of-the-First-Digital-Diagnostic-for-Autism.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/10/24/1935017/0/en/Cognoa-Launches-Pivotal-Study-of-the-First-Digital-Diagnostic-for-Autism.html</link>
      <title>Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism</title>
      <description><![CDATA[Pivotal Study Results Will be Basis of a Premarket Submission to FDA <pre>Pivotal Study Results Will be Basis of a Premarket Submission to FDA</pre>]]></description>
      <pubDate>Thu, 24 Oct 2019 13:00 GMT</pubDate>
      <dc:identifier>1935017</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Thu, 24 Oct 2019 15:45 GMT</dc:modified>
      <dc:subject>Health</dc:subject>
      <dc:subject>Product / Services Announcement</dc:subject>
      <dc:subject>Press releases</dc:subject>
      <dc:keyword>Digital Therapeutics</dc:keyword>
      <dc:keyword>digital medicine</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>Diagnostics</dc:keyword>
      <dc:keyword>pediatric behavioral health</dc:keyword>
      <dc:keyword>FDA</dc:keyword>
      <dc:keyword>clinical study</dc:keyword>
      <dc:keyword>pediatricians</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/04/10/1802043/0/en/Cognoa-Licenses-Innovative-Digital-Therapeutic-Technology.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/04/10/1802043/0/en/Cognoa-Licenses-Innovative-Digital-Therapeutic-Technology.html</link>
      <title>Cognoa Licenses Innovative Digital Therapeutic Technology</title>
      <description><![CDATA[Technology will be productized into readily accessible digital applications and incorporated into Cognoa’s precision health platform <pre>Technology will be productized into readily accessible digital applications and incorporated into Cognoa’s precision health platform</pre>]]></description>
      <pubDate>Wed, 10 Apr 2019 13:04 GMT</pubDate>
      <dc:identifier>1802043</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Wed, 10 Apr 2019 13:04 GMT</dc:modified>
      <dc:subject>Company Announcement</dc:subject>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>Stanford</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>autism spectrum disorder</dc:keyword>
      <dc:keyword>artificial intelligence</dc:keyword>
      <dc:keyword>machine learning</dc:keyword>
      <dc:keyword>google glass</dc:keyword>
      <dc:keyword>medical device</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/02/06/1711471/0/en/Cognoa-Receives-FDA-Breakthrough-Designations-for-Autism-Diagnostic-and-Digital-Therapeutic-Devices.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/02/06/1711471/0/en/Cognoa-Receives-FDA-Breakthrough-Designations-for-Autism-Diagnostic-and-Digital-Therapeutic-Devices.html</link>
      <title>Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices</title>
      <description><![CDATA[Company announces first digital therapeutic device and precision health platform to support the developmental and behavioral health of children <pre>Company announces first digital therapeutic device and precision health platform to support the developmental and behavioral health of children</pre>]]></description>
      <pubDate>Wed, 06 Feb 2019 14:04 GMT</pubDate>
      <dc:identifier>1711471</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Wed, 06 Feb 2019 14:04 GMT</dc:modified>
      <dc:subject>Company Announcement</dc:subject>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>child development</dc:keyword>
      <dc:keyword>child health</dc:keyword>
      <dc:keyword>diagnostics</dc:keyword>
      <dc:keyword>therapeutics</dc:keyword>
      <dc:keyword>digital health</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>autism spectrum disorder</dc:keyword>
      <dc:keyword>behavioral health</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2019/01/08/1682126/0/en/Cognoa-Selected-by-Cambia-Health-Solutions-to-Provide-Support-for-Employees-Raising-Young-Children.html</guid>
      <link>https://www.globenewswire.com/news-release/2019/01/08/1682126/0/en/Cognoa-Selected-by-Cambia-Health-Solutions-to-Provide-Support-for-Employees-Raising-Young-Children.html</link>
      <title>Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children</title>
      <description><![CDATA[<p align="left">PALO ALTO, Calif., Jan.  08, 2019  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Zca9kFK_e55cpxudjaUYO7Hb9acnNOxxTLPNP1MiiE7_-bW_mmYiSbgRw_uLqW51y8q1DBGDYq3chIn05g-Bxw==" rel="nofollow" target="_blank" title=""><u>Cognoa</u></a>, a digital behavioral health company, announced today that <a href="https://www.globenewswire.com/Tracker?data=abb68BirGQnPQBolwuf8B1er_MlO_1lnoGjW582IQuF-DLezrgczAeNHivwK1JJQSYXSDsFSU-mmNY2pz2U4atNLcod0ag2zaUc5OJCDFdQ=" rel="nofollow" target="_blank" title=""><u>Cambia Health Solutions, Inc</u></a>. (Cambia) is incorporating Cognoa’s evidence-based platform within its subsidiary health plans. Cognoa provides support for employees caring for children older than one. Cognoa offers reliable guidance on day-to-day challenges and personalized resources that enable parents to assess, track, and positively impact their children’s unique developmental growth.<br></p>]]></description>
      <pubDate>Tue, 08 Jan 2019 14:03 GMT</pubDate>
      <dc:identifier>1682126</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Tue, 08 Jan 2019 14:03 GMT</dc:modified>
      <dc:subject>Company Announcement</dc:subject>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>employees</dc:keyword>
      <dc:keyword>employee benefits</dc:keyword>
      <dc:keyword>Enterprise</dc:keyword>
      <dc:keyword>human resources</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>autism spectrum disorder</dc:keyword>
      <dc:keyword>employers</dc:keyword>
      <dc:keyword>machine learning</dc:keyword>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2018/11/15/1652376/0/en/LEARN-Behavioral-Announces-Partnership-with-Cognoa-to-Empower-Parents-and-Enable-Earlier-Diagnosis.html</guid>
      <link>https://www.globenewswire.com/news-release/2018/11/15/1652376/0/en/LEARN-Behavioral-Announces-Partnership-with-Cognoa-to-Empower-Parents-and-Enable-Earlier-Diagnosis.html</link>
      <title>LEARN Behavioral Announces Partnership with Cognoa to Empower Parents and Enable Earlier Diagnosis</title>
      <description><![CDATA[<p align="left">BALTIMORE, Md. and PALO ALTO, Calif., Nov.  15, 2018  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Qk8hCoTCFfy95csK93ZTHlA-BmkOPtk4yTVjTd61tlXH3vlj4bGO9GGAUQ1yYMFlASlFGfvbA3tFZCWnJotaHoa90sr6VH-_6UYNI0eXPis=" rel="nofollow" target="_blank" title=""><u>LEARN Behavioral</u></a>, the leading network of providers serving children with autism and other special needs, today announces a partnership with digital behavioral health company, <a href="https://www.globenewswire.com/Tracker?data=5URUy4-etQ3vUuE0vDDTKemx-MuLjQ8HYfoqAZwilr0NzmUbdACXwug3E6nSTn4JCMvE-fxEX2JbqK2zlnrv4w==" rel="nofollow" target="_blank" title=""><u>Cognoa, Inc</u></a>., designed to improve the timeliness of care and give more children the greatest opportunity for improved outcomes. Cognoa’s solution will be deployed in nine regions within the LEARN network, including several through Autism Spectrum Therapies (AST), LEARN’s largest provider of Applied Behavior Analysis (ABA) treatment. In total, LEARN serves more than 4,000 families annually across the country.<br></p>]]></description>
      <pubDate>Thu, 15 Nov 2018 14:04 GMT</pubDate>
      <dc:identifier>1652376</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Cognoa</dc:contributor>
      <dc:modified>Thu, 15 Nov 2018 14:04 GMT</dc:modified>
      <dc:subject>Partnerships</dc:subject>
      <dc:keyword>Cognoa</dc:keyword>
      <dc:keyword>child health</dc:keyword>
      <dc:keyword>child development</dc:keyword>
      <dc:keyword>LEARN Behavioral</dc:keyword>
      <dc:keyword>autism</dc:keyword>
      <dc:keyword>autism spectrum disorder</dc:keyword>
      <dc:keyword>Enterprise</dc:keyword>
    </item>
  </channel>
</rss>